| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_52f2e6de1c6f5a3ba7b48c7196e249b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_73638e2dd05fa3704f7a8d36bdcd6f9b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_191663f2561f98d0ba67c91203359033
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d2aa040fc89c3b1b7c0f63027580e940
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8bad861dfb9e6f31b4b84aa9d3af22bf |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6432
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-00 |
| filingDate |
2006-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_811c46e05b4ea9c37bad8d5915647639
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e64988bdca38fc7f3b77cf7b2d412dbf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0514892d2db7f0dfd9c854165a18e716
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41ff42a0681212142b1ef04b8d7349b9 |
| publicationDate |
2006-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006128668-A2 |
| titleOfInvention |
Coagulation factor x polypeptides with modified activation properties |
| abstract |
The present invention relates to modified cDNA sequences coding for human Factor X and their derivatives with improved stability and modified activation sequences, recombinant expression vectors containing such cDNA sequences and host cells transformed with such recombinant expression vectors. The invention also relates to recombinant factor X polypeptides and derivatives which do have biological activities of the unmodified wild type protein but with improved stability and processes for the manufacture of such recombinant proteins and their derivatives. The invention also covers a transfer vector for use in human gene therapy, which comprises such modified DNA. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9856467-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-3001729-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9145552-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104995297-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10364424-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101942619-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014118481-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20150113205-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9347051-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9249404-B2 |
| priorityDate |
2005-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |